Acceleron Pharma (XLRN) Gets a Buy Rating from Morgan Stanley

Retrieved on: 2021-02-26 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Acceleron Pharma (XLRN) Gets a Buy Rating from Morgan Stanley. View article details on hiswai:

Excerpt

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Acceleron Pharma (XLRN) today and set a price target of $145.00. The company's ...

Article found on: www.smarteranalyst.com